New Two-Pronged radiation attack tested for returning prostate cancer
NCT ID NCT06105918
Summary
This early-stage study is testing the safety of a new two-part radiation treatment for men whose prostate cancer has returned after surgery. First, patients receive a targeted external beam radiation guided by a special PET scan. Then, they receive a radioactive drug designed to seek out and destroy remaining cancer cells. The goal is to see if this combination is safe and to find the best dose of the radioactive drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.